Gene: FASTKD1
Official Full Name: FAST kinase domains 1provided by HGNC
Gene Summary: Enables RNA binding activity. Involved in mitochondrial RNA metabolic process and regulation of mitochondrial mRNA stability. Located in mitochondrion. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO17697 | FASTKD1 Knockout cell line (HeLa) | Human | FASTKD1 | 1:3~1:6 | Negative | Online Inquiry |
KO17698 | FASTKD1 Knockout cell line (HCT 116) | Human | FASTKD1 | 1:2~1:4 | Negative | Online Inquiry |
KO17699 | FASTKD1 Knockout cell line (HEK293) | Human | FASTKD1 | 1:3~1:6 | Negative | Online Inquiry |
KO17700 | FASTKD1 Knockout cell line (A549) | Human | FASTKD1 | 1:3~1:4 | Negative | Online Inquiry |
FASTKD1 Gene Knockout Cell Lines are specialized cell models designed to facilitate research into the functions and regulatory mechanisms associated with the FASTKD1 gene. This gene plays a crucial role in mitochondrial RNA processing and translation, making it significant for understanding mitochondrial dynamics and cellular metabolism. By employing CRISPR-Cas9 gene editing technology, the FASTKD1 gene has been precisely knocked out in various cell lines, enabling scientists to investigate the phenotypic changes and biochemical pathways that are influenced by the absence of this gene.
The primary mechanism by which these knockout cell lines function involves the disruption of FASTKD1 expression, leading to alterations in mitochondrial function and energy metabolism. Researchers can leverage these models to study the implications of FASTKD1 deficiency on mitochondrial transcript stability, protein synthesis, and overall cellular health, which are vital for understanding conditions such as metabolic disorders, age-related diseases, and cancer.
The scientific importance of FASTKD1 Gene Knockout Cell Lines extends to both basic research and clinical applications. By providing an experimental platform for dissecting mitochondrial biology, these models can enhance drug discovery efforts aimed at targeting mitochondrial dysfunction and related pathologies. Furthermore, they can aid in the development of novel therapeutic strategies, thereby offering insights into new treatment avenues for mitochondrial diseases.
Compared to traditional knockout models, our FASTKD1 cell lines offer a higher degree of specificity and efficiency, reducing off-target effects and enabling clearer interpretations of results. They are also adaptable for use in a variety of cellular backgrounds, enhancing their versatility for detailed mechanistic studies.
For researchers and clinicians focused on mitochondrial research and therapeutic development, the FASTKD1 Gene Knockout Cell Lines present a valuable resource that deepens the understanding of mitochondrial biology. Our company, recognized for its expertise in genetic engineering and cell model development, is committed to delivering high-quality products that empower scientific breakthroughs and improve health outcomes.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.